5 Analysts Assess Century Therapeutics: What You Need To Know
5 Analysts Assess Century Therapeutics: What You Need To Know
五位分析师评价世纪治疗公司：你需要知道什么
Across the recent three months, 5 analysts have shared their insights on Century Therapeutics (NASDAQ:IPSC), expressing a variety of opinions spanning from bullish to bearish.
近三个月，5位分析师分享了他们对世纪疗法（纳斯达克：IPSC）的见解，表达了从看好到看淡的各种观点。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您将找到他们最近的评级摘要，揭示了过去30天内情绪的变化，并将它们与前几个月进行比较。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $13.6, a high estimate of $24.00, and a low estimate of $9.00. A decline of 2.86% from the prior average price target is evident in the current average.
分析师通过他们对12个月股价目标的评估，提供更深入的洞察，透露出平均目标价为13.6美元，最高评估为24.00美元，最低为9.00美元。当前平均价格目标较前期下降了2.86%。
Investigating Analyst Ratings: An Elaborate Study
分析师评级的调查：一项详尽的研究
An...
对...
登录免费看全文
登录/注册